Wang Ru Wei - Net Worth and Insider Trading
Wang Ru Wei Net Worth
The estimated net worth of Wang Ru Wei is at least $1 Million dollars as of 2025-04-27. Wang Ru Wei is the Director of Zhejiang Conba Pharmaceutical Co Ltd and owns about 242,835 shares of Zhejiang Conba Pharmaceutical Co Ltd (SHSE:600572) stock worth over $1 Million. Details can be seen in Wang Ru Wei's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Wang Ru Wei has not made any transactions after 2018-09-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Wang Ru Wei
Wang Ru Wei Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Wang Ru Wei owns 1 companies in total, including Zhejiang Conba Pharmaceutical Co Ltd (SHSE:600572) .
Click here to see the complete history of Wang Ru Wei’s form 4 insider trades.
Insider Ownership Summary of Wang Ru Wei
Ticker | Company | Transaction Date | Type of Owner |
---|---|---|---|
SHSE:600572 | Zhejiang Conba Pharmaceutical Co Ltd | 2018-09-19 | Director |
Wang Ru Wei Latest Holdings Summary
Wang Ru Wei currently owns a total of 1 stock. Wang Ru Wei owns 242,835 shares of Zhejiang Conba Pharmaceutical Co Ltd (SHSE:600572) as of September 19, 2018, with a value of $1 Million.
Latest Holdings of Wang Ru Wei
Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
SHSE:600572 | Zhejiang Conba Pharmaceutical Co Ltd | 2018-09-19 | 242,835 | 4.51 | 1,095,186 |
Holding Weightings of Wang Ru Wei
Wang Ru Wei Form 4 Trading Tracker
According to the SEC Form 4 filings, Wang Ru Wei has made a total of 0 transactions in Zhejiang Conba Pharmaceutical Co Ltd (SHSE:600572) over the past 5 years. The most-recent trade in Zhejiang Conba Pharmaceutical Co Ltd is the acquisition of 63,000 shares on September 19, 2018, which cost Wang Ru Wei around $396,900.
Insider Trading History of Wang Ru Wei
- 1
Wang Ru Wei Trading Performance
GuruFocus tracks the stock performance after each of Wang Ru Wei's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Wang Ru Wei is -14.33%. GuruFocus also compares Wang Ru Wei's trading performance to market benchmark return within the same time period. The performance of stocks bought by Wang Ru Wei within 3 months outperforms 4 times out of 14 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Wang Ru Wei's insider trading performs compared to the benchmark.
Wang Ru Wei Ownership Network
Ownership Network List of Wang Ru Wei
Ownership Network Relation of Wang Ru Wei

Wang Ru Wei Owned Company Details
What does Zhejiang Conba Pharmaceutical Co Ltd do?
Who are the key executives at Zhejiang Conba Pharmaceutical Co Ltd?
Wang Ru Wei is the Director of Zhejiang Conba Pharmaceutical Co Ltd. Other key executives at Zhejiang Conba Pharmaceutical Co Ltd include senior management Yuan Zhen Xian , Supervisors Wu Zhong Shi , and Supervisors Ye Jian Feng .
Zhejiang Conba Pharmaceutical Co Ltd (SHSE:600572) Insider Trades Summary
Over the past 18 months, Wang Ru Wei made no insider transaction in Zhejiang Conba Pharmaceutical Co Ltd (SHSE:600572). Other recent insider transactions involving Zhejiang Conba Pharmaceutical Co Ltd (SHSE:600572) include a net sale of 0 shares made by Hu Ji Qiang ,
In summary, during the past 3 months, insiders sold 0 shares of Zhejiang Conba Pharmaceutical Co Ltd (SHSE:600572) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Zhejiang Conba Pharmaceutical Co Ltd (SHSE:600572) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Zhejiang Conba Pharmaceutical Co Ltd (SHSE:600572)'s detailed insider trading history can be found in Insider Trading Tracker table.
Zhejiang Conba Pharmaceutical Co Ltd Insider Transactions
Wang Ru Wei Mailing Address
Above is the net worth, insider trading, and ownership report for Wang Ru Wei. Currently GuruFocus does not have mailing address information for Wang Ru Wei.